Acta Scientific Medical Sciences (ISSN: 2582-0931)

Research Article Volume 4 Issue 3

Factors Associated with Low Virulence in the Infective COVID-19 Virus in Africa with the Pandemic infection Rise

Maurice B Silali*

Maseno University, Kenya

*Corresponding Author: Maurice B Silali, Maseno University, Kenya.

Received: March 26, 2020; Published: April 01, 2020



  Distribution and determinants of low virulence in the contagious/communicable COVID-19, among the population health of the black race of Tropical climate remains unclear, since its discovery in Wuhan China 2019. We define Health from the World Health organization, (WHO) definition of 1948 [11] which is now terrorizing most societies of the World to remain into the vicious cycle due to persistence skewed economy, poverty and illness. In February 2020, WHO re named COVID novel Corona or Wuhan china virus, which is air borne disease that may remain viable in the environment for over 8hrs susceptible to population health, due to its attributed global pandemic infection with varying virulence among the various continents. COVID-19 is caused by a virus similar to the Severe Acute Respiratory syndrome - COV-2 [SARS] of (2002), of the animal reservoir Bats, that was spread by the intermediate host (civet cats), and also first discovered in southern China in 2002. The reservoir host for COVID-19 virus is also Bat animal which when spread to the intermediate host, Pangolin animal [ant heater], it undergoes the gene mediation that is potentially infectious to population health. The incubation period of COVID-19, [time interval of exposure to agent of infection to onset of symptoms] of COVID-19, ranges from 5 to 24 days, when inhaled or comes in contact with the susceptible human population. The onset of signs and symptoms may include: fever [pyrexia], sneezing, short breath for mild cases, while susceptible host may develop severe symptoms such pneumonia and septic shock due to entry of the viruses into blood vessels and severe conditions are common to population health of cohort age above 60 years and above, hypertension and diabetic mellitus population. The Current treatment of COVID-19, is basically supportive care which involve provision of intra venous fluids to replenish the lost body fluids besides regular medication Chloroquine tablets used to treat malaria, Ritovir for HIV and Remdesivir used to treat Ebola cases in 2014 which were used to manage COVID 19 in Wuhan china in 2020. Despite the fact that COVID-19 has high infection to population health its Virulence remain low specifically in Black race located in tropical Africa compared other corona virus such SARS, and Ebola whose virulence is deadly to population health.

Keywords: COVID-19; Air Borne; Hand Washing; Infection; Virulence; Immunity; Supportive Care; Tropical Climate



  1. Casona LM., et al. “Effect of high temperatures and relative humidity on corona virus survival on the dry surfaces” 76 (2019): 12-27.
  2. Daniel JK. "In the Name of Eugenics: Genetics and the Uses of Human Heredity". University of California Press volume 2 (2012): 277-237.
  3. Gradys D. “China begins testing of antiviral drugs to manage COVID-2 Corona virus” (2020).
  4. Li Wenliang. “An alarm on the emergence of CoviD-2 corona virus in Wuhan china” (2019).
  5. Haines A and S Kuruvilla. "Bridging the implementation gap between knowledge and action for health". Bulletin of the World Health Organization 10 (2004): 724-732.
  6. Health Act. Section 80, In Kenya autopsies are required for purposes of aiding a legal process and state Planning purpose to create data base that help health sector for Policy formation page 8 and 9 (2017).
  7. Singleton A., et al. “Approaches to social research”. Oxford University, Press: New York (1998).
  8. Southerland B. "Participation Research in Natural resources, social-economic”. Trainer’s Guide for Participatory learning and Action London (1998).
  9. Leon Gordis. “Principles of epidemiology”. Third edition (2004).
  10. , et al. “Redmsivir and chloroquine inhibits COVID 19 reproduction in vitro” (2020).
  11. “Health, State of complete physical, mental, social, emotional, spiritual, and environmental well-being and not merely the absence of diseases or infirmity” (1948).
  12. "Health challenges are influenced by bad health practices which forms major difficulty in achieving quality healthcare in developing countries" (1997).
  13. “Effects of SARs on the population health in southern China” (2005).
  14. “Middle East Respiratory Syndrome Corona virus, MERs- COVID out breaks in Saudi Arabia and Korea” (2012).
  15. “Cost of management of Ebola disease in West Africa, epicene error” (2014).
  16. “Preventive and treatment of the novel corona viruses in Wuhan china” (2019).
  17. “Functional assessment of the cell entry and receptor usage for linear B. Beta corona virus” (2020).
  18. Wu J., et al. “Costing and forecasting the potential intervention on the spread of COVID 2019”. Lancet (2020).


Citation: Maurice B Silali. “Factors Associated with Low Virulence in the Infective COVID-19 Virus in Africa with the Pandemic infection Rise". Acta Scientific Medical Sciences 4.3 (2020): 01-04.


Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US